Stanley Tennant serves as Executive at TrovaGene Inc., where they oversee executive responsibilities. Since joining the company, Stanley Tennant has executed 12 insider transactions totaling $303.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 8, 2018 involved purchasing 10,000 shares valued at $8.0K.
Stanley Tennant currently holds 236,061 shares of TrovaGene Inc. (TROV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stanley Tennant has been a net buyer of TROV stock. They have purchased $298.0K and sold $5.8K worth of shares.
Stanley Tennant's most recent insider trade was on Jun 8, 2018, when they purchased 10,000 shares at $0.80 per share.
Get notified when new Form 4 filings are submitted
| $0.80 |
| Discretionary |
| Jan 2, 2018 | TROV | $0 | Option Exercise | 16,667 | $N/A | Discretionary |
| Jan 2, 2018 | TROV | $0 | Option Exercise | 16,667 | $N/A | Discretionary |
| Sep 5, 2017 | TROV | $5.8K | Sale | 8,334 | $0.69 | Discretionary |
| Sep 2, 2017 | TROV | $0 | Option Exercise | 8,484 | $N/A | Discretionary |
| Dec 19, 2016 | TROV | $21.0K | Purchase | 10,000 | $2.10 | Discretionary |
| Dec 16, 2016 | TROV | $29.9K | Purchase | 14,966 | $2.00 | Discretionary |
| Aug 12, 2015 | TROV | $60.6K | Purchase | 10,000 | $6.06 | Discretionary |
| Dec 31, 2012 | BKOR | $1.3K | Award | 350 | $3.75 | Discretionary |
| Nov 30, 2012 | TROV | $120.5K | Purchase | 25,000 | $4.82 | Discretionary |
| Apr 13, 2012 | TROV | $50.0K | Purchase | 100,000 | $0.50 | Discretionary |